Pages • 1
Case 2 Amgen Inc.’s Epogen Case Executive Summary Essay Preview: Case 2 Amgen Inc.’s Epogen Case Executive Summary Report this essay MMI1050 – Case 2 Amgen Inc.’s Epogen Case Executive SummaryJane Dong, Al-Qaim Mitha, Andrew Schellenbach, Shannon ZhengIssues Amgen Inc. has started a patent war with Genetics Institute over the production of EPO. Neither company was.